ScripThe number of initial public offerings in the US by biopharmaceutical companies in 2023 may be able to at least match the number of IPOs in 2022 now that another company has made its stock market debu
ScripAmylyx Hopes Sunnybrook Might Discover New Methods For Fighting ALS Although it is in the midst of a protracted effort to obtain US Food and Drug Administration approval for its investigational mitoch